Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07078422 · ClinicalTrials.gov registry record · NA
Home Use Study of Targeted Mechanical Stimulation for Tremor Relief
A NA study of Essential Tremor and Parkinson's Disease, sponsored by Encora.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT07078422: Recruiting NA study of Essential Tremor and Parkinson's Disease, sponsored by Encora.
NCT07078422 is a NA study of Essential Tremor and Parkinson's Disease that is actively recruiting participants, run by Encora. The registered enrollment target is 80 participants, below the 401-participant average among 41 other Essential Tremor trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07078422, a NA study of Essential Tremor and Parkinson's Disease, is actively recruiting participants, sponsored by Encora.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
Subjects will receive prototype devices to be used for participation. The study comprises three phases: 1. Alpha phase: Two remote study visits and an in-home period to gather device usability data on the alpha system. The at home period for this phase will be 2 weeks. This phase will be used to confirm that the device and labeling are suitable for in-home use. 2. Beta Phase B1: Beta Phase B1 will be conducted using the beta devices for two in-person or remote, 60 to 90-minute, visits. This phase will be used to assess design changes between alpha and beta versions. 3. Beta Phase B2: Seven remote visits and in-home usage to gather usability and efficacy data on the beta system in-home. Beta Phase B2 will be conducted using the beta devices for 12 weeks. This phase will be used to assess design changes between alpha and beta versions.
Primary Outcome
This outcome measure assesses participants' experiences through an open-ended survey. Participants will be asked to describe their perceptions, symptoms, and overall experiences with the treatment. No predefined responses are given, and answers will be analyzed qualitatively
Conditions Studied
Interventions
- DEVICE Encora Pulse
Study Locations (1)
Massachusetts
- Encora Therapeutics - Cambridge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2025-01-01 |
| Est. Completion | 2026-06 |
| Phase | NA |
What NCT07078422 shows while recruiting
NCT07078422 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 401-participant average among 41 other Essential Tremor trials with a reported enrollment target (80% lower).
The record links to 2 conditions, with Essential Tremor appearing as the primary indexed condition, and to 1 intervention - of which Encora Pulse is the first listed.
NCT07078422 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07078422 about?
NCT07078422 is a clinical study titled "Home Use Study of Targeted Mechanical Stimulation for Tremor Relief". Subjects will receive prototype devices to be used for participation. The study comprises three phases: 1. Alpha phase: Two remote study visits and an in-home period to gather device usability data on the alpha system. The at home period for this phase will be 2 weeks. This phase will be used to co...
What is the current status of trial NCT07078422?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2025-01-01. Estimated completion is 2026-06.
What conditions does trial NCT07078422 study?
This clinical trial studies the following conditions: Essential Tremor, Parkinson's Disease.
What interventions are being tested in trial NCT07078422?
The interventions under investigation include: Encora Pulse (DEVICE).
Who is sponsoring clinical trial NCT07078422?
This trial is sponsored by Encora, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07078422 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Essential Tremor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07078422's enrollment target sits among peer trials
80 16th of 41 higher than 24 of 41 other Essential Tremor trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Essential Tremor trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Circadian Adaptive DBS in Essential Tremor
RECRUITING · NA
-
Motor Network Physiology
RECRUITING · NA
-
Investigating Subcortical Contributions to Speech Sequencing in Deep Brain Stimulator Recipients
RECRUITING · NA
-
3-D Tractography FUS Ablation for Essential Tremor
RECRUITING · NA
-
Directional Versus Nondirectional DBS for ET
RECRUITING · NA
-
Elucidating the Temporality of Structural and Functional Connectivity Changes in Essential Tremor After Successful Deep Brain Stimulation to the Dentato-rubro-thalamic Tract
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI